Advertisement

LFST

LifeStance Health Group, Inc.

Healthcare · USD

Set alert

Price alert · LFST

All alert types
13.40 USD -0.23 -1.72%
As of Oct 30, 2026 Extended hours 13.40 0.00%
Bid
13.41 × 2
Ask
13.42 × 2
13.27 Day range 13.76
4.81 52-week range 13.64
YTD
+90.34%
1 year
+172.91%
Open
13.69
Prev close
13.64
Mkt cap
5.09B
Vol
2.30M
Avg vol
4.41M
EPS
0.13
P/E
103.08
Div yield
0.00%
More statistics
Low
13.27
High
13.76
Forward P/E
31.11
Beta
1.24
Short ratio
2.99
Inst. own
89.66%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
12.47
200-d avg
9.31
1y target
14.45

5D chart

Chart tools
Interval
LFST five-day price chart12.412.713.013.313.6Oct 23Oct 26Oct 27Oct 28Oct 29

Key statistics

Market cap
5.09B
Enterprise value
5.46B
Trailing P/E
103.08
Forward P/E
31.11
PEG ratio
0.00
Price / sales
3.21
Price / book
3.47
EPS (TTM)
0.13
Beta
1.24
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
3.19%
Revenue (TTM)
1.58B
Revenue growth
26.10%
Free cash flow
172.36M
Total cash
225.94M
Total debt
474.15M
Return on equity
3.43%
Shares outstanding
380.15M
Short % of float
7.54%
50-day average
12.47
200-day average
9.31

Analyst view

Consensus: buy

Buy
Price target (mean) 14.45 +7.8% upside
Target (low)
12.00
Target (mean)
14.45
Target (high)
18.00
Ratings (0m) 11 9 buy · 2 hold · 0 sell
  • Strong buy2
  • Buy7
  • Hold2
  • Sell0
  • Strong sell0

Next earnings

Nov 5, 2026

Expected Nov 5, 2026. Consensus EPS estimate 0.08388.

Earnings history

Financials — quick view

All financials
LFST Revenue — quarterly 435.35M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
LFST Net income — quarterly 23.61M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
LFST EPS — quarterly 0.06
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

LFST recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Sep 30, 20260.03687———
Aug 6, 2026Jun 30, 20260.032750.06+0.03+83.21%
May 7, 2026Mar 31, 20260.010.04+0.03+300.00%
Feb 25, 2026Dec 31, 2025-0.000940.03+0.03+3,291.49%
Nov 6, 2025Sep 30, 2025-0.010.00277+0.01+127.70%
Aug 7, 2025Jun 30, 2025-0.03-0.01+0.02+66.67%

Upgrades / downgrades

LFST analyst upgrades and downgrades
DateFirmActionFromTo
Oct 5, 2026KeybancmainOverweightOverweight
Sep 10, 2026BarclaysmainOverweightOverweight
Sep 9, 2026Canaccord GenuitymainBuyBuy
Aug 19, 2026BTIGmainBuyBuy
Aug 14, 2026JP MorganmainNeutralNeutral
Aug 7, 2026BTIGmainBuyBuy

About LifeStance Health Group, Inc.

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Sector
Healthcare
Industry
Medical Care Facilities
Country
United States

News

Your note

Sign in to keep a note on LFST — it syncs with the Stock Master app.

Insider holders

LFST insider holders
InsiderRelationLatest transactionDateShares held
BESSLER ROBERTDirectorStock Award(Grant)Jul 1, 20261,308,050
BLACK DARREN MDirectorSaleMay 11, 20260
BOURDON DAVIDChief Executive OfficerStock Award(Grant)Mar 8, 20261,398,250
BURDICK KENNETH ADirectorSaleAug 10, 20263,017,320
PANTALEONI PABLOOfficerSaleMar 9, 20250
PARDO RYANOfficer and DirectorStock Award(Grant)Mar 8, 20263,654,260

Institution ownership

LFST institution ownership
Holder% heldSharesValueReported
TPG GP A, LLC29.24%111,744,6141.50BJun 29, 2026
FMR, LLC15.24%58,252,466780.58MJun 29, 2026
Blackrock Inc.9.51%36,348,507487.07MJun 29, 2026
Summit Partners, L.P.4.35%16,623,824222.76MSep 29, 2026
Vanguard Portfolio Management LLC3.65%13,960,892187.08MJun 29, 2026
Jennison Associates LLC3.16%12,077,557161.84MJun 29, 2026

Fund ownership

LFST fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF4.21%16,071,660215.36MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.76%6,740,31190.32MJun 29, 2026
Fidelity Securities Fund-Fidelity Small Cap Value Fund1.71%6,520,53787.38MJul 30, 2026
iShares Trust-iShares Russell 2000 ETF1.69%6,465,18786.63MSep 29, 2026
Variable Insurance Products Fund II-VIP Contrafund Portfolio1.55%5,911,33779.21MAug 30, 2026
Fidelity Securities Fund-Fidelity Small Cap Growth Fund1.42%5,442,41972.93MJul 30, 2026
Advertisement